Mucinous Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-03-15
Clinical Trial Update: BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei [Phase 2]
Phase 2 clinical trial update for BromAc in recurrent pseudomyxoma peritonei and peritoneal mucinous tumors; current status is unknown.